ADIAL PHARMACEUTICALS, INC. Quarterly Current Ratio in % from Q1 2019 to Q4 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Adial Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2019 to Q4 2023.
  • Adial Pharmaceuticals, Inc. Current Ratio for the quarter ending December 31, 2023 was 272 %, a 43.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 272 -210 -43.6% Dec 31, 2023
Q3 2023 239 -208 -46.6% Sep 30, 2023
Q2 2023 308 -120 -28.1% Jun 30, 2023
Q1 2023 361 -3.48 -0.96% Mar 31, 2023
Q4 2022 482 +188 +64.2% Dec 31, 2022
Q3 2022 447 +124 +38.6% Sep 30, 2022
Q2 2022 428 +62.7 +17.1% Jun 30, 2022
Q1 2022 364 -180 -33.1% Mar 31, 2022
Q4 2021 293 -489 -62.5% Dec 31, 2021
Q3 2021 322 -833 -72.1% Sep 30, 2021
Q2 2021 366 -999 -73.2% Jun 30, 2021
Q1 2021 544 -905 -62.5% Mar 31, 2021
Q4 2020 782 -974 -55.5% Dec 31, 2020
Q3 2020 1.16K -699 -37.7% Sep 30, 2020
Q2 2020 1.36K -762 -35.8% Jun 30, 2020
Q1 2020 1.45K +521 +56.2% Mar 31, 2020
Q4 2019 1.76K Dec 31, 2019
Q3 2019 1.86K Sep 30, 2019
Q2 2019 2.13K Jun 30, 2019
Q1 2019 927 Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.